Tenax Therapeutics, Inc.
TENX
$14.06
$0.221.55%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -52.60M | -43.33M | -31.48M | -24.21M | -17.60M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.16M | 15.34M | 9.74M | 5.16M | 1.15M |
| Change in Net Operating Assets | -2.36M | 2.07M | 1.90M | 2.44M | 1.64M |
| Cash from Operations | -35.80M | -25.91M | -19.84M | -16.61M | -14.81M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | -279.00K | -413.00K | -501.00K |
| Issuance of Common Stock | 15.30M | 3.69M | 2.45M | 2.17M | 1.83M |
| Repurchase of Common Stock | -- | -1.76M | -1.76M | -1.76M | -1.76M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 23.22M | 25.04M | 115.51M | 115.51M | 100.30M |
| Cash from Financing | 38.51M | 26.97M | 115.92M | 115.51M | 99.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.71M | 1.06M | 96.08M | 98.90M | 85.06M |